Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Live Attenuated Polio Vaccine Market Grown from 2024 to 2025?

The market for live attenuated polio vaccines has seen significant growth lately. The market size is projected to increase from $1.85 billion in 2024 to $2.00 billion in 2025, growing at a compound annual growth rate (CAGR) of 8.3%. Factors such as mass vaccination drives, rising concerns over vaccine-derived poliovirus, government-led immunization initiatives, increased public awareness and education, along with the accessibility and affordability of the vaccine, have contributed to the historical period’s growth.

What Growth Rate Is Anticipated for the Live Attenuated Polio Vaccine Market in the Coming Years?

The market for live attenuated polio vaccine is predicted to significantly expand in the forthcoming years. It is projected to reach a value of $2.71 billion in 2029, growing at a Compound Annual Growth Rate (CAGR) of 7.9%. This growth during the forecasted period can be accredited to factors such as enhanced vaccine stability and longevity, a rise in polio cases in conflict-ridden areas, a lack of enthusiasm from donors in eradication programs, the development of standard immunization initiatives, and an uptick in research for the production of safer live attenuated vaccine strains. Notable trends during this estimated period include the appearance of vaccine-derived poliovirus, progression in the field of oral polio vaccine, advancements in vaccine formulation technology, the incorporation of digital technologies, and collaborations between public and private sectors.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24280&type=smp

Who Are the Leading Companies in the Live Attenuated Polio Vaccine Market?

Major companies operating in the live attenuated polio vaccine market are Sanofi Pasteur, GlaxoSmithKline plc, LG Chem Ltd., Serum Institute of India Pvt. Ltd., Biological E. Limited, Indian Immunologicals Limited, Sinovac Biotech Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Vabiotech, Emergent BioSolutions Inc., Valneva SE, Bio Farma, PT Bio Farm, Bilthoven Bio, Panacea Biotec, Haffkine Biopharmaceutical, Panacea Biotec Ltd., Zydus Cadila, Liaoning Cheng Da Biotechnology Co.Ltd, Bharat Biotech International Limited

What Are the Key Drivers of the Live Attenuated Polio Vaccine Market?

The growth of the live attenuated polio vaccine market is anticipated to surge with the broadening of immunization programs. Such programs are concerted initiatives aimed at preventing the spread of infectious diseases through vaccination, undertaken by governments, health bodies, or other organizations. The extension of these programs attributes to a heightened global conscientiousness about disease prevention bolstered by solid backing from governments, international health agencies, and funding entities. Immunization agendas advance the live attenuated polio vaccine (LAPV) market via ensuring an extensive distribution, safe usage, and widespread coverage, thereby contributing to herd immunity, halting virus transfer, and supporting the worldwide eradication of polio. Case in point being in October 2023, as per the US-based Centers for Disease Control and Prevention, global coverage for the initial dose of the diphtheria-tetanus-pertussis (DTP) vaccine escalated from 86% to 89% between 2021 and 2022. As such, the enlargement of immunization programs is fueling the development of the live attenuated polio vaccine market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24280&type=smp

What Are the Key Market Segments in the Live Attenuated Polio Vaccine Industry?

The live attenuated polio vaccine market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Bivalent, Trivalent

2) By Administration Route: Oral Administration, Intramuscular Injection, Subcutaneous Injection

3) By Age Group: Infants (0-1 years), Children (1-5 years), Adults (Above 5 years)

4) By End-User: Hospitals, Clinics, Public Health Agencies, Other End-Users

Subsegments:

1) Monovalent: mOPV1 For Serotype 1

2) Bivalent: Type 1, Type 3

3) Trivalent: Poliovirus Type 1, Poliovirus Type 2, Poliovirus Type 3

What Are the Latest Trends in the Live Attenuated Polio Vaccine Market?

Leading corporations in the live attenuated polio vaccine market are prioritizing acquiring regulatory permissions to confirm their vaccines align with the safety and efficiency criteria set by global health agencies. Such approvals are essentially official permissions extended by government health organizations or regulatory entities, facilitating a product like a vaccine’s marketability, sale, and usage within a particular territory or country. For example, in July 2024, Biological E, a pharmaceutical and biologics enterprise based in India, achieved the World Health Organization (WHO)’s approval for its innovative oral polio vaccine type 2 (nOPV2). This modern, live, attenuated oral vaccine is created to tackle the issues related to conventional oral polio vaccines. This advanced vaccine is made to battle outbreaks of circulating vaccine-derived poliovirus type 2 (cVDPV2) more effectively than the preceding version. nOPV2 is built with high genetic stability, diminishing the possibility of the vaccine virus changing back into a dangerous form, which was a worry with previous vaccines.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/live-attenuated-polio-vaccine-global-market-report

What Are the Key Regional Markets in the Live Attenuated Polio Vaccine Industry?

North America was the largest region in the live attenuated polio vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the live attenuated polio vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/customise?id=24280&type=smp

This Report Delivers Insight On:

1. How big is the live attenuated polio vaccine market, and how is it changing globally?

2. Who are the major companies in the live attenuated polio vaccine market, and how are they performing?

3. What are the key opportunities and risks in the live attenuated polio vaccine market right now?

4. Which products or customer segments are growing the most in the live attenuated polio vaccine market?

5. What factors are helping or slowing down the growth of the live attenuated polio vaccine market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model